Philippe Lesnik
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 10
- Immunology top 2%
- Atherosclerosis and Cardiovascular Diseases 16
- Phagocytosis and Immune Regulation 11
- Cancer Research top 2%
- Surgery top 1%
- Lipoproteins and Cardiovascular Health 14
- Cholesterol and Lipid Metabolism 9
-
- Lipid metabolism and disorders 7
-
- Adipokines, Inflammation, and Metabolic Diseases 10
- Liver Disease Diagnosis and Treatment 7
- Co-authors
- M. John ChapmanIsrael CharoChristopher A. HaskellEdward A. FisherOlivier DescampsL. MasanaKausik K. RayHenry N. Ginsberg
- Journals
- Arteriosclerosis Thrombosis and Vascular Biology (11 papers)Atherosclerosis (6 papers)Circulation (3 papers)
- Partner nations
- FranceUnited StatesAustralia
In The Last Decade
Philippe Lesnik
87 papers receiving 5.7k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Endocrinology, Diabetes and Metabolism 1.6k
- Immunology 1.5k
- Cancer Research 937
- Surgery 2.6k
- Cardiology and Cardiovascular Medicine 1.1k
Countries citing papers authored by Philippe Lesnik
This map shows the geographic impact of Philippe Lesnik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Lesnik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Lesnik more than expected).
Fields of papers citing papers by Philippe Lesnik
This network shows the impact of papers produced by Philippe Lesnik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Lesnik. The network helps show where Philippe Lesnik may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Philippe Lesnik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 4 | |
| 4 | 2020 | 120 | |
| 5 | Impaired Kupffer Cell Self-Renewal Alters the Liver Response to Lipid Overload during Non-alcoholic Steatohepatitisbreakdown → | 2020 | 256 |
| 6 | 2019 | 21 | |
| 7 | 2019 | 5 | |
| 8 | 2019 | 148 | |
| 9 | 2017 | 6 | |
| 10 | 2017 | 25 | |
| 11 | 2017 | 7 | |
| 12 | 2017 | 5 | |
| 13 | 2016 | 2 | |
| 14 | 2015 | 46 | |
| 15 | 2011 | 91 | |
| 16 | 2011 | 39 | |
| 17 | The standardized Ginkgo biloba extract Egb-761 protects vascular endothelium exposed to oxidized low density lipoproteins. | 2008 | 15 |
| 18 | 2008 | 62 | |
| 19 | 2006 | 97 | |
| 20 | 1999 | 11 |
About Philippe Lesnik
Philippe Lesnik is a scholar working on Immunology, Immunology and Allergy, Biochemistry, Endocrinology, Diabetes and Metabolism and Surgery, having authored 89 papers that have together received 5.9k indexed citations. Recurring topics across this work include Atherosclerosis and Cardiovascular Diseases (16 papers), Lipoproteins and Cardiovascular Health (14 papers), Phagocytosis and Immune Regulation (11 papers), Adipokines, Inflammation, and Metabolic Diseases (10 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers), Cholesterol and Lipid Metabolism (9 papers), Lipid metabolism and disorders (7 papers) and Liver Disease Diagnosis and Treatment (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.6k citations), Immunology (1.5k citations), Cancer Research (937 citations), Surgery (2.6k citations) and Cardiology and Cardiovascular Medicine (1.1k citations). Philippe Lesnik has collaborated with scholars based in France, United States and Australia. Frequent co-authors include M. John Chapman, Israel Charo, Christopher A. Haskell, Edward A. Fisher, Olivier Descamps, L. Masana, Kausik K. Ray, Henry N. Ginsberg, Pierre Amarenco and Marja‐Riitta Taskinen. Their work appears in journals such as Arteriosclerosis Thrombosis and Vascular Biology, Atherosclerosis, Circulation, European Heart Journal and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.